Literature DB >> 10210358

Absence of age-related increase in systolic blood pressure in ambulatory patients with HIV infection.

J Mattana1, F P Siegal, R T Sankaran, P C Singhal.   

Abstract

BACKGROUND: Systolic blood pressure is well known to increase significantly with age and is strongly correlated with stroke and coronary artery disease. We and other investigators have reported a low prevalence of hypertension in subgroups of patients with HIV infection. In the present study, we examined an ambulatory population of patients with HIV infection to determine whether in the outpatient setting they may lack an age-related increase in systolic blood pressure.
METHODS: In an ambulatory outpatient practice, medical records of 178 consecutive patients with HIV infection and those of 200 control subjects were examined. Systolic and diastolic blood pressure and other clinical and laboratory variables were recorded. Scatter plots were generated to compare age with systolic blood pressure. Spearman rank correlation analysis was carried out to determine the relationship between systolic blood pressure and age and other variables.
RESULTS: Patients ranged in age from 13 to 69 years. There was only a very slight increase (which did not achieve statistical significance) in systolic blood pressure with aging in the patients with HIV infection, in contrast to the control population, in which an age-related increase in systolic blood pressure was seen that was comparable to published Framingham data. Mean systolic blood pressure for the group as a whole was 118.2 +/- 1.1 mm Hg. Mean serum albumin was 4.2 +/- 0.04 g/dL and was only slightly diminished in older patients. Mean serum cholesterol was 176.8 +/- 3.4 mg/dL and this bore no relationship to aging. More advanced stages of HIV infection also did not correlate with the lack of age-associated systolic hypertension.
CONCLUSION: The present population of ambulatory patients infected with HIV seem to lack an age-related increase in systolic blood pressure; this may be caused by such variables as autonomic dysfunction or factors that may attenuate the development of atherosclerosis.

Entities:  

Mesh:

Year:  1999        PMID: 10210358     DOI: 10.1097/00000441-199904000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  14 in total

Review 1.  Hypertension in the HIV-infected patient.

Authors:  S Aoun; E Ramos
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  A comparative analysis of blood pressure in HIV-infected patients versus uninfected controls residing in Sub-Saharan Africa: a narrative review.

Authors:  Edith Phalane; Carla M T Fourie; Catharina M C Mels; Aletta E Schutte
Journal:  J Hum Hypertens       Date:  2020-07-24       Impact factor: 3.012

Review 3.  Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.

Authors:  Bente Magny Bergersen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Lipoatrophy and lipohypertrophy are independently associated with hypertension.

Authors:  Heidi M Crane; C Grunfeld; R D Harrington; M M Kitahata
Journal:  HIV Med       Date:  2009-05-20       Impact factor: 3.180

5.  Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.

Authors:  B M Bergersen; L Sandvik; O Dunlop; K Birkeland; J N Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-11       Impact factor: 3.267

6.  Blood pressure trajectories and the mediated effects of body mass index and HIV-related inflammation in a mixed cohort of people with and without HIV in rural Uganda.

Authors:  Samson Okello; June-Ho Kim; Ruth N Sentongo; Russell Tracy; Alexander C Tsai; Bernard Kakuhikire; Mark J Siedner
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-06       Impact factor: 3.738

7.  Determinants of hypertension in a young adult Ugandan population in epidemiological transition-the MEPI-CVD survey.

Authors:  James Kayima; Joaniter Nankabirwa; Isaac Sinabulya; Jane Nakibuuka; Xiaofeng Zhu; Mahboob Rahman; Christopher T Longenecker; Achilles Katamba; Harriet Mayanja-Kizza; Moses R Kamya
Journal:  BMC Public Health       Date:  2015-08-28       Impact factor: 3.295

8.  Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.

Authors:  Paula Freitas; Davide Carvalho; Ana Cristina Santos; António José Madureira; Sandra Xerinda; Esteban Martinez; Jorge Pereira; António Sarmento; José Luís Medina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

9.  Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross-sectional study in Uganda.

Authors:  Samson Okello; Peter Ueda; Michael Kanyesigye; Emmanuel Byaruhanga; Achilles Kiyimba; Gideon Amanyire; Alex Kintu; Wafaie W Fawzi; Winnie R Muyindike; Goodarz Danaei
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-12       Impact factor: 3.738

Review 10.  Vitamin D receptor and epigenetics in HIV infection and drug abuse.

Authors:  Nirupama Chandel; Ashwani Malhotra; Pravin C Singhal
Journal:  Front Microbiol       Date:  2015-08-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.